Product Information

PRENATE DHA SOFTGEL is a brand product labeled by Avion Pharmaceuticals, LLC, priced at $12.8208 per EA under NDC 75854031230. Its NADAC has been published 471 times since Mar 18, 2015.

Strength

40; 90; 155; 400; 25; 300; 18; 1; 50; 26 [iU]/1; mg/1; mg/1; [iU]/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1

NDC

75854031230

Classification

Brand

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Effective Date

1/1/2026

Approval Type

Unapproved

On Market Since

6/5/2014

Pharmacological Classes

Analogs/Derivatives [Chemical/Ingredient]
Ascorbic Acid
Blood Coagulation Factor
Calcium
Calculi Dissolution Agent
Cations
Divalent
Increased Coagulation Factor Activity
Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Small Intestine Fluid/Electrolyte Absorption
Magnesium Ion Exchange Activity
Osmotic Activity
Osmotic Laxative
Phosphate Binder
Phosphate Chelating Activity
Stimulation Large Intestine Fluid/Electrolyte Secretion
Vitamin B 12
Vitamin B 6 [Chemical/Ingredient]
Vitamin B12
Vitamin B6 Analog
Vitamin C
Vitamin D
Vitamin D

Price Statistics

The NADAC for PRENATE DHA SOFTGEL has been published 471 times since Mar 18, 2015, and over the history we have for it it has risen 218.4%. The table below summarizes its recorded NADAC range and movement.

Current price$12.8208 per EA
All-time high$12.8208 (Aug 19, 2026)
All-time low$4.0267 (Mar 18, 2015)
52-week high$12.8208
52-week low$12.4311
Median price$7.3254
Average price$8.1485
Largest weekly change+26.8% (Jun 19, 2024)
Weeks tracked471
Tracking sinceMar 18, 2015

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+3.1%

3Y

+34.3%

5Y

+34.3%

All

+218.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ascorbic acid, cholecalciferol, .alpha.-tocopherol, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, calcium formate, ferrous asparto glycinate, magnesium oxide and doconexent market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of PRENATE DHA SOFTGEL?

The current National Average Drug Acquisition Cost (NADAC) for PRENATE DHA SOFTGEL, manufactured by Avion Pharmaceuticals, LLC, is $12.8208 per EA (NDC 75854031230), effective Aug 19, 2026.

How has the price of PRENATE DHA SOFTGEL changed over time?

Over the history we have for it, the NADAC for PRENATE DHA SOFTGEL has risen 218.4%. It has been tracked across 471 weekly CMS publications since Mar 18, 2015.

What are the highest and lowest recorded NADAC prices for PRENATE DHA SOFTGEL?

Since Mar 18, 2015, the NADAC for PRENATE DHA SOFTGEL has ranged from a low of $4.0267 (Mar 18, 2015) to a high of $12.8208 (Aug 19, 2026), with a median of $7.3254 per EA.

Are there cheaper alternatives to PRENATE DHA SOFTGEL?

No other NADAC-published product currently shares the active ingredient and strength of PRENATE DHA SOFTGEL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PRENATE DHA SOFTGEL?

PRENATE DHA SOFTGEL (NDC 75854031230) is labeled by Avion Pharmaceuticals, LLC, and CMS classifies it as a brand product.